The EuroBiotech Journal (Oct 2017)

Genetic testing for Best vitelliform macular dystrophy

  • Abeshi Andi,
  • Bruson Alice,
  • Beccari Tommaso,
  • Dundar Munis,
  • Viola Francesco,
  • Colombo Leonardo,
  • Bertelli Matteo

DOI
https://doi.org/10.24190/ISSN2564-615X/2017/S1.05
Journal volume & issue
Vol. 1, no. s1
pp. 17 – 19

Abstract

Read online

We studied the scientific literature and disease guidelines in order to summarize the clinical utility of the genetic test for Best vitelliform macular dystrophy (BVMD). BVMD is mostly inherited in an autosomal dominant manner (autosomal recessive transmission is rare). The overall prevalence is currently unknown. BVMD is caused by mutations in the BEST1 gene. Clinical diagnosis is based on clinical findings, ophthalmological examination, optical coherence tomography, electrooculography and electroretinography. The genetic test is useful for confirming diagnosis, and for differential diagnosis, couple risk assessment and access to clinical trials.